Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية الصباغ - sabbagh drug store - human anti rh(d) immunoglobulin 300 mcg - 300 mcg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ki biopharma llc, united states - anti-d [rho] immunoglobulin - solution for injection - 600 iu

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ki biopharma llc, united states - anti-d [rho] immunoglobulin - solution for injection - 1500 iu

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

csl behring, switzerland - anti-d (rh0) immunoglobulin - solution for injection - 300 µg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

instituto grifols, spain - human rho(d) immune globulin - solution for injection - 750 iu/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - immunoglobulin human normal - solution for injection - 200 microgram

Ireland - English - HPRA (Health Products Regulatory Authority)

cangene europe limited - anti-d immunoglobulin sodium chloride - pdr+solv for soln for inj - 1500 international unit

Ireland - English - HPRA (Health Products Regulatory Authority)

cangene europe limited - anti-d immunoglobulin sodium chloride - pdr+solv for soln for inj - 5000 international unit

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - anti-d [rho] immunoglobulin 250 [iu] - solution for injection - 250 iu - active: anti-d [rho] immunoglobulin 250 [iu] - rh(d) immunoglobulin-vf is indicated for the prevention of rh sensitisation in rh(d) negative females at or below child bearing age.

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - anti-d [rho] immunoglobulin 625 [iu] - solution for injection - 625 iu - active: anti-d [rho] immunoglobulin 625 [iu] excipient: glycine water for injection - rh(d) immunoglobulin-vf is indicated for the prevention of rh sensitisation in rh(d) negative females at or below child bearing age.